These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 12787640)
1. Preparation of sustained-release nitrendipine microspheres with Eudragit RS and Aerosil using quasi-emulsion solvent diffusion method. Yang Ms; Cui Fd; You Bg; Fan Yl; Wang L; Yue P; Yang H Int J Pharm; 2003 Jun; 259(1-2):103-13. PubMed ID: 12787640 [TBL] [Abstract][Full Text] [Related]
2. Design of sustained-release nitrendipine microspheres having solid dispersion structure by quasi-emulsion solvent diffusion method. Cui F; Yang M; Jiang Y; Cun D; Lin W; Fan Y; Kawashima Y J Control Release; 2003 Sep; 91(3):375-84. PubMed ID: 12932715 [TBL] [Abstract][Full Text] [Related]
3. [Preparation of sustained-release nitrendipine microspheres with a solid dispersed structure in liquid system]. Yang MS; Cui FD; Yang H; Gao P; Yue P; Wang L; Fan YL Yao Xue Xue Bao; 2003 Aug; 38(8):634-8. PubMed ID: 14628460 [TBL] [Abstract][Full Text] [Related]
4. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique. Jelvehgari M; Barar J; Valizadeh H; Shadrou S; Nokhodchi A Pharm Dev Technol; 2011; 16(6):637-44. PubMed ID: 20722498 [TBL] [Abstract][Full Text] [Related]
5. Physicomechanical properties of naproxen-loaded microparticles prepared from Eudragit l100. Maghsoodi M AAPS PharmSciTech; 2009; 10(1):120-8. PubMed ID: 19184624 [TBL] [Abstract][Full Text] [Related]
6. Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique. Maghsoodi M; Esfahani M Pharm Dev Technol; 2009; 14(4):442-50. PubMed ID: 19235551 [TBL] [Abstract][Full Text] [Related]
7. A novel pH-dependent gradient-release delivery system for nitrendipine: I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs. Yang M; Cui F; You B; You J; Wang L; Zhang L; Kawashima Y J Control Release; 2004 Aug; 98(2):219-29. PubMed ID: 15262414 [TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: effect of variables. Devrim B; Canefe K Acta Pol Pharm; 2006; 63(6):521-34. PubMed ID: 17438870 [TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations. Nath B; Nath LK; Kumar P Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196 [TBL] [Abstract][Full Text] [Related]
10. The influence of stirring rate on biopharmaceutical properties of Eudragit RS microspheres. Mateovic T; Kriznar B; Bogataj M; Mrhar A J Microencapsul; 2002; 19(1):29-36. PubMed ID: 11811756 [TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of solid dispersions of nitrendipine prepared with fine silica particles using the melt-mixing method. Wang L; Cui FD; Sunada H Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):37-43. PubMed ID: 16394546 [TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique. Maghsoodi M; Sadeghpoor F Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658 [TBL] [Abstract][Full Text] [Related]
13. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres. Rawat M; Saraf S; Saraf S AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537 [TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of Eudragit S 100 microspheres as pH-sensitive release preparations for piroxicam and theophylline using the emulsion-solvent evaporation method. Obeidat WM; Price JC J Microencapsul; 2006 Mar; 23(2):195-202. PubMed ID: 16754375 [TBL] [Abstract][Full Text] [Related]
15. A novel pH-dependent gradient-release delivery system for nitrendipine II. Investigations of the factors affecting the release behaviors of the system. Yang M; Cui F; You B; Wang L; Yue P; Kawashima Y Int J Pharm; 2004 Nov; 286(1-2):99-109. PubMed ID: 15501006 [TBL] [Abstract][Full Text] [Related]
16. DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE. Majeed A; Ranjha NM; Hanif M; Abbas G; Khan MA Acta Pol Pharm; 2017 Mar; 74(2):565-578. PubMed ID: 29624261 [TBL] [Abstract][Full Text] [Related]
17. Effect of formulation variables on in vitro drug release and micromeritic properties of modified release ibuprofen microspheres. Perumal D; Dangor CM; Alcock RS; Hurbans N; Moopanar KR J Microencapsul; 1999; 16(4):475-87. PubMed ID: 10420332 [TBL] [Abstract][Full Text] [Related]
18. Effect of amount of water in dispersed phase on drug release characteristics of dextran microspheres prepared by emulsion-solvent evaporation process. Miyazaki Y; Yakou S; Takayama K Biol Pharm Bull; 2007 Mar; 30(3):543-6. PubMed ID: 17329853 [TBL] [Abstract][Full Text] [Related]
19. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization. Xu H; Zhong H; Liu M; Xu C; Gao Y Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119 [TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Haznedar S; Dortunç B Int J Pharm; 2004 Jan; 269(1):131-40. PubMed ID: 14698584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]